Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes.

Ponnazhagan S, Weigel KA, Raikwar SP, Mukherjee P, Yoder MC, Srivastava A.

J Virol. 1998 Jun;72(6):5224-30.

2.

Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.

Kurpad C, Mukherjee P, Wang XS, Ponnazhagan S, Li L, Yoder MC, Srivastava A.

J Hematother Stem Cell Res. 1999 Dec;8(6):585-92.

PMID:
10645765
4.

Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2.

Ponnazhagan S, Woody MJ, Wang XS, Zhou SZ, Srivastava A.

J Virol. 1995 Dec;69(12):8096-101.

6.
8.

Recombinant human parvovirus B19 vectors.

Weigel-Kelley KA, Srivastava A.

Pathol Biol (Paris). 2002 Jun;50(5):295-306. Review.

PMID:
12116848
9.

Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood.

Zhou SZ, Cooper S, Kang LY, Ruggieri L, Heimfeld S, Srivastava A, Broxmeyer HE.

J Exp Med. 1994 Jun 1;179(6):1867-75.

11.

Recombinant self-complementary adeno-associated virus serotype vector-mediated hematopoietic stem cell transduction and lineage-restricted, long-term transgene expression in a murine serial bone marrow transplantation model.

Maina N, Han Z, Li X, Hu Z, Zhong L, Bischof D, Weigel-Van Aken KA, Slayton WB, Yoder MC, Srivastava A.

Hum Gene Ther. 2008 Apr;19(4):376-83. doi: 10.1089/hum.2007.143.

PMID:
18370591
12.

High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.

Song L, Li X, Jayandharan GR, Wang Y, Aslanidi GV, Ling C, Zhong L, Gao G, Yoder MC, Ling C, Tan M, Srivastava A.

PLoS One. 2013;8(3):e58757. doi: 10.1371/journal.pone.0058757.

13.

Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression.

Qing K, Hansen J, Weigel-Kelley KA, Tan M, Zhou S, Srivastava A.

J Virol. 2001 Oct;75(19):8968-76.

14.

Parvovirus-based vectors for human gene therapy.

Srivastava A.

Blood Cells. 1994;20(2-3):531-6; discussion 536-8. Review.

PMID:
7538355
15.

Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.

Fraefel C, Jacoby DR, Lage C, Hilderbrand H, Chou JY, Alt FW, Breakefield XO, Majzoub JA.

Mol Med. 1997 Dec;3(12):813-25.

16.
17.
18.

Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.

Byun J, Heard JM, Huh JE, Park SJ, Jung EA, Jeong JO, Gwon HC, Kim DK.

J Mol Cell Cardiol. 2001 Feb;33(2):295-305.

PMID:
11162134
19.

Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.

Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL, Young NS, Liu JM.

J Clin Invest. 1994 Oct;94(4):1440-8.

20.

Enhanced transgene expression from recombinant single-stranded D-sequence-substituted adeno-associated virus vectors in human cell lines in vitro and in murine hepatocytes in vivo.

Ling C, Wang Y, Lu Y, Wang L, Jayandharan GR, Aslanidi GV, Li B, Cheng B, Ma W, Lentz T, Ling C, Xiao X, Samulski RJ, Muzyczka N, Srivastava A.

J Virol. 2015 Jan 15;89(2):952-61. doi: 10.1128/JVI.02581-14.

Items per page

Supplemental Content

Support Center